Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence-Reference-Cited by-同舟云学术

Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence

Published:2017-06-19 Issue:7 Volume:12 Page:692-700
ISSN:1748-3387
Container-title:Nature Nanotechnology
language:en
Short-container-title:Nature Nanotech

Author:

Xue Jingwei,Zhao Zekai,Zhang Lei,Xue Lingjing,Shen Shiyang,Wen Yajing,Wei Zhuoyuan,Wang Lu,Kong Lingyi,Sun Hongbin,Ping Qineng,Mo Ran,Zhang Can

Publisher

Springer Science and Business Media LLC

Subject

Electrical and Electronic Engineering,Condensed Matter Physics,General Materials Science,Biomedical Engineering,Atomic and Molecular Physics, and Optics,Bioengineering

Link

http://www.nature.com/articles/nnano.2017.54.pdf

Reference54 articles.

1. Gladson, C. L., Prayson, R. A. & Liu, W. M. The pathobiology of glioma tumors. Annu. Rev. Pathol. 5, 33–50 (2010).

2. Agrawal, N. S. et al. Current studies of immunotherapy on glioblastoma. J. Neurol. Neurosurg. 1, 1000104 (2014).

3. Huse, J. T. & Holland, E. C. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat. Rev. Cancer 10, 319–331 (2010).

4. Park, J. K. et al. Scale to predict survival after surgery for recurrent glioblastoma multiforme. J. Clin. Oncol. 28, 3838–3843 (2010).

5. Lacroix, M. et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J. Neurosurg. 95, 190–198 (2001).

Cited by 719 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA polymer conjugates: Revolutionizing neurological disorder treatment through targeted drug delivery;Next Materials;2025-04

2. Recent advances in biomimetic strategies for the immunotherapy of glioblastoma;Biomaterials;2024-12

3. X-ray-activatable hitchhiking polymer nanodrugs enable controllable ferroptosis and immunization for orthotopic glioma rejection;Chemical Engineering Journal;2024-10

4. Harnessing cells to improve transport of nanomedicines;European Journal of Pharmaceutics and Biopharmaceutics;2024-10

5. Leukocyte-based delivery systems for enhanced nanotheranostics of inflammation and cancer;Nanotechnology;2024-09-10